• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MIB-1标记指数对中枢神经细胞瘤的预后价值

Prognostic value of the MIB-1 labeling index for central neurocytomas.

作者信息

Rades Dirk, Schild Steven E, Fehlauer Fabian

机构信息

Department of Radiation Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

出版信息

Neurology. 2004 Mar 23;62(6):987-9. doi: 10.1212/01.wnl.0000115392.21898.e3.

DOI:10.1212/01.wnl.0000115392.21898.e3
PMID:15037708
Abstract

Although central neurocytomas are generally described as benign CNS lesions, malignant behavior including craniospinal dissemination and tumor-related death may occur. This meta-analysis was performed to investigate the prognostic value of the MIB-1 labeling index. Data were obtained not from the literature alone but also from contact with the authors. The data suggested an MIB-1 index score of >3% to be associated with a worse prognosis for local control (p < 0.0001) and survival (p = 0.0004).

摘要

尽管中枢神经细胞瘤通常被描述为良性中枢神经系统病变,但仍可能出现包括颅脊髓播散和肿瘤相关死亡在内的恶性行为。进行这项荟萃分析以研究MIB-1标记指数的预后价值。数据不仅从文献中获取,还通过与作者联系获得。数据表明,MIB-1指数评分>3%与局部控制预后较差(p<0.0001)和生存预后较差(p = 0.0004)相关。

相似文献

1
Prognostic value of the MIB-1 labeling index for central neurocytomas.MIB-1标记指数对中枢神经细胞瘤的预后价值
Neurology. 2004 Mar 23;62(6):987-9. doi: 10.1212/01.wnl.0000115392.21898.e3.
2
Atypical and rare variants of central neurocytomas.中枢神经细胞瘤的非典型及罕见变体。
Neurosurg Clin N Am. 2015 Jan;26(1):91-8. doi: 10.1016/j.nec.2014.09.003. Epub 2014 Oct 18.
3
Central neurocytomas with MIB-1 labeling index over 10% showing rapid tumor growth and dissemination.MIB-1标记指数超过10%的中枢神经细胞瘤显示肿瘤生长迅速且有播散。
J Neurooncol. 2006 Sep;79(2):211-6. doi: 10.1007/s11060-006-9129-x. Epub 2006 Mar 22.
4
Estimation of proliferative potentiality of central neurocytoma: correlational analysis of minimum ADC and maximum SUV with MIB-1 labeling index.中枢神经细胞瘤增殖潜能的评估:最小表观扩散系数(ADC)和最大标准化摄取值(SUV)与MIB-1标记指数的相关性分析
Acta Radiol. 2015 Jan;56(1):114-20. doi: 10.1177/0284185114521187. Epub 2014 Jan 29.
5
Atypical central neurocytoma.非典型中枢神经细胞瘤。
J Neuropathol Exp Neurol. 1997 May;56(5):551-6. doi: 10.1097/00005072-199705000-00011.
6
Atypical extraventricular neurocytoma:A report of two cases.非典型性脑室外神经细胞瘤:两例报告
J Cancer Res Ther. 2015 Oct-Dec;11(4):1022. doi: 10.4103/0973-1482.146135.
7
MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas.MIB-1 标记指数可预测脑室中枢神经细胞瘤的复发。
J Clin Neurosci. 2013 Jan;20(1):89-93. doi: 10.1016/j.jocn.2012.05.025. Epub 2012 Nov 5.
8
Atypia predicting prognosis for intracranial extraventricular neurocytomas.非典型性预测颅内脑室外神经细胞瘤的预后。
J Neurosurg. 2012 Feb;116(2):349-54. doi: 10.3171/2011.9.JNS10783. Epub 2011 Nov 4.
9
Proliferative activity of central neurocytoma: measurement of tumor volume doubling time, MIB-1 staining index and bromodeoxyuridine labeling index.中枢神经细胞瘤的增殖活性:肿瘤体积倍增时间、MIB-1染色指数及溴脱氧尿苷标记指数的测定
J Neurooncol. 1997 Apr;32(2):103-9. doi: 10.1023/a:1005740205113.
10
The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.Ki-67/MIB-1 标记指数在人脑膜瘤中的意义:文献研究。
Pathol Res Pract. 2010 Dec 15;206(12):810-5. doi: 10.1016/j.prp.2010.09.002. Epub 2010 Oct 15.

引用本文的文献

1
The clinical spectrum of central neurocytomas ranges from benign to leptomeningeal disseminating disease: a single institutional surgical series of 33 patients.中枢神经细胞瘤的临床谱从良性到软脑膜播散性疾病:一个机构的33例患者手术系列报道
Front Surg. 2025 Jul 18;12:1534566. doi: 10.3389/fsurg.2025.1534566. eCollection 2025.
2
Treatment of Central Neurocytoma.中枢神经细胞瘤的治疗
Cancers (Basel). 2025 Jun 16;17(12):2005. doi: 10.3390/cancers17122005.
3
Outcome-associated factors in a molecularly defined cohort of central neurocytoma.
分子定义的中枢神经细胞瘤队列中的预后相关因素。
Acta Neuropathol. 2025 Jun 11;149(1):61. doi: 10.1007/s00401-025-02894-3.
4
Intraventricular neurocytoma: A diagnostic challenge with prognostic value.脑室内神经细胞瘤:一项具有预后价值的诊断挑战。
Radiol Case Rep. 2024 Jul 18;19(10):4151-4157. doi: 10.1016/j.radcr.2024.06.055. eCollection 2024 Oct.
5
Long-term outcomes of central neurocytoma - an institutional experience.中枢神经细胞瘤的长期预后-一项机构经验。
J Neurooncol. 2024 Aug;169(1):195-201. doi: 10.1007/s11060-024-04713-3. Epub 2024 Jun 12.
6
Gamma Knife radiosurgery for central neurocytoma: a quantitative systematic review and metanalysis.伽玛刀放射外科治疗中枢神经细胞瘤:一项定量系统评价和荟萃分析。
Neurosurg Rev. 2024 Jan 24;47(1):64. doi: 10.1007/s10143-024-02301-7.
7
The role of single fraction Gamma Knife radiosurgery for intraventricular central neurocytomas and the utility of F-18 fluroethyltyrosine: two case reports.单次分割伽玛刀放射外科治疗脑室内中枢神经细胞瘤的作用及F-18氟乙基酪氨酸的应用:两例报告
J Med Case Rep. 2022 Nov 28;16(1):441. doi: 10.1186/s13256-022-03665-4.
8
Comparison of surgery with or without adjuvant radiotherapy in treating central neurocytoma: a single-center retrospective real-world study.对比手术联合或不联合辅助放疗治疗中枢神经细胞瘤的疗效:单中心回顾性真实世界研究。
J Neurooncol. 2022 Nov;160(2):455-462. doi: 10.1007/s11060-022-04164-8. Epub 2022 Oct 28.
9
Malignant transformation of central neurocytoma with dissemination 17 years after initial treatment: illustrative case.初始治疗17年后中枢神经细胞瘤发生恶性转化并播散:病例报告
J Neurosurg Case Lessons. 2022 Feb 7;3(6). doi: 10.3171/CASE21610.
10
Central neurocytomas in children: Clinicopathologic features and long-term surgical outcomes.儿童中枢神经细胞瘤:临床病理特征及长期手术结果
Childs Nerv Syst. 2023 Jan;39(1):141-150. doi: 10.1007/s00381-022-05663-9. Epub 2022 Sep 12.